VA's Aduhelm Restrictions: Big Symbolism But Small Impact?

Biogen is ‘pleased’ access will be available through exceptions process in formulary restrictions though the US veterans agency does not expect there will be ‘significant’ interest among its clinicians in prescribing through that process. Price was not deciding factor, agency says.

VA Takes A Tough Stance On Covering Aduhelm

More from Market Access

More from Pink Sheet